{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:58:09Z","timestamp":1768917489352,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jcjo.2021.03.001","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T08:44:07Z","timestamp":1617785047000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis"],"prefix":"10.1016","volume":"57","author":[{"given":"Miaoli","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Anesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Eggenschwiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambika","family":"Manhapra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-5653","authenticated-orcid":false,"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2021.03.001_bib0001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000271","article-title":"Retinal vasculitis","volume":"28","author":"Rosenbaum","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00055735-200312000-00015","article-title":"Retinal vasculitis","volume":"14","author":"Walton","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0004","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bjophthalmol-2013-303443","article-title":"The course of retinal vasculitis","volume":"98","author":"Ali","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","article-title":"Beh\u00e7et disease: visual prognosis and factors influencing the development of visual loss","volume":"152","author":"Taylor","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0006","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/bjophthalmol-2013-303265","article-title":"Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study","volume":"97","author":"Yen","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ceo.12997","article-title":"Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions","volume":"46","author":"Agarwal","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2017.02.028","article-title":"Tomkins-Netzer O. Clinical outcome of retinal vasculitis and predictors for prognosis of ischemic retinal vasculitis","volume":"177","author":"Sharief","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0009","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/IAE.0000000000001019","article-title":"Visual outcome and poor prognostic factors in isolated idiopathic retinal vasculitis","volume":"36","author":"Maleki","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1442-9071.2004.00766.x","article-title":"Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment","volume":"32","author":"Au","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.semarthrit.2011.10.006","article-title":"Patients with retinal vasculitis rarely suffer from systemic vasculitis","volume":"41","author":"Rosenbaum","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.survophthal.2004.04.008","article-title":"Ocular manifestations and concepts of systemic vasculitides","volume":"49","author":"Perez","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0013","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/09273949709085062","article-title":"Immunology and ocular manifestations of giant cell arteritis","volume":"5","author":"Barchuk","year":"1997","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajo.2017.12.004","article-title":"Characteristics and visual outcome of refractory retinal vasculitis associated with antineutrophil cytoplasm antibody-associated vasculitides","volume":"187","author":"Lin","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0016","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ophtha.2015.10.056","article-title":"Risk of retinal neovascularization in cases of uveitis","volume":"123","author":"Patel","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0017","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-005-0307-8","article-title":"Neovascularization of the optic disc in Beh\u00e7et's disease","volume":"50","author":"Tugal-Tutkun","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09273948.2017.1332228","article-title":"Biologic treatment options for retinal neovascularization in Beh\u00e7et's disease","volume":"27","author":"Markomichelakis","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0021","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s10067-018-4133-z","article-title":"Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies","volume":"37","author":"Fabiani","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0022","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/09273948.2017.1327602","article-title":"Rituximab induction and maintenance treatment in patients with scleritis and granulomatosis with polyangiitis (Wegener's)","volume":"26","author":"You","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0023","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40932","article-title":"Rituximab as maintenance treatment for systemic lupus erythematosus: a multicenter observational study of 147 patients","volume":"71","author":"Cassia","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0026","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/eye.1996.71","article-title":"Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis","volume":"10","author":"Palmer","year":"1996","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2021.03.001_bib0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2017.1351570","article-title":"Ocular manifestations and visual outcomes of Beh\u00e7et's uveitis in a Thai population","volume":"27","author":"Pathanapitoon","year":"2019","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:10:50Z","timestamp":1757794250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418221000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0008418221000910"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.03.001","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}